Pharmaceutical Control of the
Human Microbiome

Pharmaceutical Journal  Highlights Research by UNC Professor and Founder of Symberix

March 2015

Dr. Matthew Redinbo, Kenan Distinguished Professor of Chemistry, Biochemistry and Microbiology, University of North Carolina, Chapel Hill, and Founder and Chief Scientific Officer of Symberix, was featured in Pharmaceutical Journal in an interview about the microbiome. For more information, click here Drug metabolism: manipulating the microbiome.



Back to News